Bal Pharma Share PriceBal Pharma

₹95.2
-0.35 (-0.37%)
As on 04 October, 2023 | 04:45 BSE: 524824 NSE: BALPHARMAISIN: INE083D01012

Bal Pharma Performance

Day Range

  • Low 93.1
  • High 96.9
95.2

52 Week Range

  • Low 63.35
  • High 106.5
95.2
  • Open Price94.15
  • Previous Close95.55
  • Volume16836

Start SIP in Bal Pharma

Start SIP

Bal Pharma Share Price

  • Over 1 Month -1.65%
  • Over 3 Month 6.79%
  • Over 6 Month 32.68%
  • Over 1 Year 0.95%

Bal Pharma Key Statistics

P/E Ratio 62.6
PEG Ratio -1.3
Market Cap Cr 149
Price to Book Ratio 2.3
EPS 3.9
Dividend 1.1
Relative Strength Index 49.83
Money Flow Index 41.93
MACD Signal -0.18
Average True Range 3.16

Bal Pharma Investment Rating

  • Master Rating:
  • Bal Pharma has an operating revenue of Rs. 304.76 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 2% needs improvement, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 48%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 114 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bal Pharma Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 708277757074
Operating Expenses Qtr Cr 637470696470
Operating Profit Qtr Cr 786653
Depreciation Qtr Cr 222222
Interest Qtr Cr 443322
Tax Qtr Cr 010000
Net Profit Qtr Cr 121113
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 305287
Operating Expenses Annual Cr 277257
Operating Profit Annual in Cr 2623
Depreciation Cr 77
Interest Annual Cr 1210
Tax Annual Cr 23
Net Profit Annual Cr 69
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 31
Cash from Investing Activity Annual Cr -13
Cash from Financing Annual Activity Cr -18
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 9687
Fixed Assets Annual Cr 7154
Total Non Current Assets Annual Cr 7869
Total Current Assets Annual Cr 270220
Total Assets Annual Cr 348290
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 6159
ROE Annual % 610
ROCE Annual % 1518
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 911
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 708277757074
Operating Expenses Qtr Cr 647470706571
Operating Profit Qtr Cr 686653
Depreciation Qtr Cr 322222
Interest Qtr Cr 443322
Tax Qtr Cr 010000
Net Profit Qtr Cr 021002
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 305286
Operating Expenses Annual Cr 279258
Operating Profit Annual in Cr 2523
Depreciation Cr 99
Interest Annual Cr 1210
Tax Annual Cr 23
Net Profit Annual Cr 36
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 28
Cash from Investing Activity Annual Cr -9
Cash from Financing Annual Activity Cr -18
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 6459
Fixed Assets Annual Cr 7365
Total Non Current Assets Annual Cr 8576
Total Current Assets Annual Cr 228185
Total Assets Annual Cr 313261
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 4139
ROE Annual % 410
ROCE Annual % 1621
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 910

Bal Pharma Technicals

EMA & SMA

Current Price
₹95.2
-0.35 (-0.37%)
  • Bullish Moving Average
  • ___
  • 12
  • Bearish Moving Average
  • ___
  • 4
  • 20 Day
  • ₹95.19
  • 50 Day
  • ₹94.65
  • 100 Day
  • ₹92.2
  • 200 Day
  • ₹90.4
  • 20 Day
  • ₹95.65
  • 50 Day
  • ₹95.76
  • 100 Day
  • ₹92.4
  • 200 Day
  • ₹86.31

Bal Pharma Resistance and Support

PIVOT
₹95.07
Resistance
First Resistance ₹97.04
Second Resistance ₹98.87
Third Resistance ₹100.84
RSI 49.83
MFI 41.93
MACD Single Line -0.18
MACD -0.26
Support
First Resistance ₹93.24
Second Resistance ₹91.27
Third Resistance ₹89.44

Bal Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 22,496 1,163,493 51.72
Week 16,126 950,481 58.94
1 Month 36,764 2,240,419 60.94
6 Month 78,087 3,535,779 45.28

Bal Pharma Result Highlights

Bal Pharma Synopsis

NSE-Medical-Diversified

Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 303.10 Cr. and Equity Capital is Rs. 15.69 Cr. for the Year ended 31/03/2023. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.
Market Cap 149
Sales 304
Shares in Float 0.75
No of funds 1
Yield 1.05
Book Value 1.54
U/D Vol ratio 1.9
LTDebt / Equity 32
Alpha 0.04
Beta 0.17

Bal Pharma

Owner NameJun-23Mar-23Dec-22
Promoters 51.61%51.61%51.61%
Foreign Portfolio Investors 0.17%0.17%0.18%
Individual Investors 31.99%32.07%32.13%
Others 16.23%16.15%16.08%

Bal Pharma Management

Name Designation
Mr. Shailesh D Siroya Managing Director
Mr. Himesh Virupakshaya Executive Director
Mr. Jatish Sheth Independent Director
Dr. C V Srinivas Independent Director
Ms. Nicloa Neeladri Independent Director
Mr. H S Venkatesh Additional Director
Mr. Kotian Chittananda Damodar Additional Director

Bal Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bal Pharma Corporate Action

Date Purpose Remarks
2023-08-11 Quarterly Results & A.G.M.
2023-05-29 Audited Results & Final Dividend
2023-02-06 Quarterly Results
2022-11-14 Quarterly Results & ESOP Inter alia, To convene Extra Ordinary General Meeting ( EGM ) for merger of Golden Drugs Pvt Ltd. a wholly owned subsidiary of the Company. per share(10%)Final Dividend
2022-08-11 Quarterly Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Bal Pharma FAQs

What is Share Price of Bal Pharma ?

Bal Pharma share price is ₹95 As on 04 October, 2023 | 04:31

What is the Market Cap of Bal Pharma ?

The Market Cap of Bal Pharma is ₹149.4 Cr As on 04 October, 2023 | 04:31

What is the P/E ratio of Bal Pharma ?

The P/E ratio of Bal Pharma is 62.6 As on 04 October, 2023 | 04:31

What is the PB ratio of Bal Pharma ?

The PB ratio of Bal Pharma is 2.3 As on 04 October, 2023 | 04:31

Q2FY23